apl. Prof. Dr. Dr. Axel Hueber

Medizinische Fakultät Department of Medicine 3 – Rheumatology and Immunology

Prediction of Response to Certolizumab-Pegol in Rheumatoid Arthritis By Functional MRI of the Brain - an Interim Analysis of an Ongoing Investigator Initiated Phase III Trial (2017) Schenker H, Heß A, Konerth L, Sergeeva M, Prade J, Kleyer A, Reiser M, et al. Conference contribution INCREASE OF CORTICAL MICRO-CHANNELS (COMICS) AS A NEW FEATURE OF STRUCTURAL DAMAGE IN PAIENTS WITH RHEUMATOID ARTHRITIS (2017) Werner D, Simon D, Englbrecht M, Stemmler F, Berlin A, Haschka J, Renner N, et al. Conference contribution "Suddenly You Are a Person at Risk of Developing Rheumatoid Arthritis!" Different Perspectives of Individuals on Predictive Testing - Results of an International Qualitative Interview Study (2017) Mosor E, Stoffer M, Steiner G, Raza K, Stack RJ, Simons G, Falahee M, et al. Conference contribution Ustekinumab Is Superior to TNF Inhibitor Treatment in Resolving Enthesitis in Psa Patients with Active Enthesitis-Results from the Enthesial Clearance in Psoriatic Arthritis Study (2017) Guilhon de Araujo E, Englbrecht M, Höpken S, Finzel S, Hueber A, Rech J, Schett G Conference contribution Th2 and eosinophil responses ameliorate arthritis and inflammatory bone loss (2017) Andreev D, Chen Z, Oeser K, Krljanac B, Hueber A, Kleyer A, Weigmann B, et al. Conference contribution Serum Proteomic Signatures Predict Relapse in Rheumatoid Arthritis Patients Undergoing DMARD Withdrawal (2017) O'Neil L, Spicer V, Hitchon CA, Rech J, Hueber A, Wilkins J, El-Gabalawy H, Schett G Conference contribution QUANTIFICATION AND IMPACT OF SECONDARY OSTEOARTHRITIS USING HR-PQCT IN ANTI-CITRULLINATED PROTEIN ANTIBODY RHEUMATOID ARTHRITIS PATIENTS (2017) Figueiredo C, Simon D, Englbrecht M, Haschka J, Kleyer A, Bayat S, Hueber A, et al. Conference contribution LOW DOSE RADIATION ALTERS THE INFLAMMATORY PHENOTYPE OF FIBROBLAST-LIKE SYNOVIOCYTES AND MACROPHAGES AND STIMULATES OSTEOBLASTS (2017) Deloch L, Liberg J, Rückert M, Hueber A, Fietkau R, Frey B, Gaipl U Conference contribution FRA-1 TRANSCRIPTION FACTOR EXPRESSION IN MACROPHAGES FOSTER INFLAMMATION DURING RHEUMATOID ARTHRITIS DEVELOPMENT (2017) Hannemann N, Schnelzer A, Jordan J, Eberhardt M, Schleicher U, Hueber A, Reid S, et al. Conference contribution Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs (2017) Figueiredo CP, Bang H, Cobra JF, Englbrecht M, Hueber A, Haschka J, Manger B, et al. Journal article